Determinants of human papillomavirus vaccine uptake among Iranian adults: a nationally representative survey using the Iranian HPV Vaccine Determinants Scale (I-HPV-VDS)

Human ​papillomavirus (HPV) infection represents a major global public health burden. Despite the availability of effective vaccines, clear national policies on HPV vaccination remain absent in Iran. Understanding current HPV vaccine coverage and the factors influencing vaccine acceptance among Iranian adults is essential for guiding effective public health interventions. This cross-sectional study was conducted in 2025 using an online survey of Iranian adults. We utilized the newly developed Iranian HPV Vaccine Determinants Scale (I-HPV-VDS), which was constructed based on well-established health behavior frameworks. Psychometric assessment of the questionnaire included using face validity, construct validity, and Cronbach’s alpha. Post-stratification weighting was applied using national distributions of age, gender and educational attainment to improve population representativeness. Univariate and multivariable logistic regression analyses were used to identify determinants of HPV vaccine uptake. In the weighted sample of 1416 Iranian adults, HPV vaccine uptake was 5.5%. Vaccine uptake was significantly higher among younger adults (aOR: 2.88, 95% CI: 1.52–5.47), females (aOR: 5.90, 95% CI: 3.09–11.26), and unmarried individuals (aOR: 16.72, 95% CI: 7.64–36.57), particularly those previously married or in non-marital relationships. Each one standard deviation increase in Social Support and Self-efficacy was associated with nearly 4 times higher odds of uptake (aOR: 4.46, 95% CI: 2.43–8.18), while Risk Perception was associated with about 2 times higher odds (aOR: 2.12, 95% CI: 1.27–3.52). Interestingly, stigma-related and behavioral concern components were not independently associated with vaccination in multivariable analysis. It is of note that the wide CIs observed for several subgroups likely reflect very low event counts in specific strata combined with post-stratification weighting, which warrants cautious interpretation of these findings. The critically low HPV vaccination uptake, particularly in men, alongside profound social inequities suggest a need to consider measures to improve access, including possible inclusion of the HPV vaccine in the nation​al immunization program. Furthermore, considering recent HPV vaccination initiatives in neighboring countries and the central role of HPV vaccination in global cervical cancer elimination efforts, strengthening public understanding of HPV susceptibility and vaccine effectiveness, as well as enhancing supportive social environments within the Iranian context is essential.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2026-11-16
DOI
https://doi.org/10.1186/s12889-026-30308-w
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Determinants of human papillomavirus vaccine uptake among Iranian adults: a nationally representative survey using the Iranian HPV Vaccine Determinants Scale (I-HPV-VDS)

Mehrdad Askarian, Mohammad Hossein Taghrir, Mehrdad Vossoughi, Nahid Hatam et al.
BMC Public Health
Cervical Cancer and HPV Research
article

Determinants of human papillomavirus vaccine uptake among Iranian adults: a nationally representative survey using the Iranian HPV Vaccine Determinants Scale (I-HPV-VDS)

Mehrdad Askarian, Mohammad Hossein Taghrir, Mehrdad Vossoughi, Nahid Hatam, Ehsan Taherifard, Rosa Moazed, Parisa Zare
article en

Abstract

Human ​papillomavirus (HPV) infection represents a major global public health burden. Despite the availability of effective vaccines, clear national policies on HPV vaccination remain absent in Iran. Understanding current HPV vaccine coverage and the factors influencing vaccine acceptance among Iranian adults is essential for guiding effective public health interventions. This cross-sectional study was conducted in 2025 using an online survey of Iranian adults. We utilized the newly developed Iranian HPV Vaccine Determinants Scale (I-HPV-VDS), which was constructed based on well-established health behavior frameworks. Psychometric assessment of the questionnaire included using face validity, construct validity, and Cronbach’s alpha. Post-stratification weighting was applied using national distributions of age, gender and educational attainment to improve population representativeness. Univariate and multivariable logistic regression analyses were used to identify determinants of HPV vaccine uptake. In the weighted sample of 1416 Iranian adults, HPV vaccine uptake was 5.5%. Vaccine uptake was significantly higher among younger adults (aOR: 2.88, 95% CI: 1.52–5.47), females (aOR: 5.90, 95% CI: 3.09–11.26), and unmarried individuals (aOR: 16.72, 95% CI: 7.64–36.57), particularly those previously married or in non-marital relationships. Each one standard deviation increase in Social Support and Self-efficacy was associated with nearly 4 times higher odds of uptake (aOR: 4.46, 95% CI: 2.43–8.18), while Risk Perception was associated with about 2 times higher odds (aOR: 2.12, 95% CI: 1.27–3.52). Interestingly, stigma-related and behavioral concern components were not independently associated with vaccination in multivariable analysis. It is of note that the wide CIs observed for several subgroups likely reflect very low event counts in specific strata combined with post-stratification weighting, which warrants cautious interpretation of these findings. The critically low HPV vaccination uptake, particularly in men, alongside profound social inequities suggest a need to consider measures to improve access, including possible inclusion of the HPV vaccine in the nation​al immunization program. Furthermore, considering recent HPV vaccination initiatives in neighboring countries and the central role of HPV vaccination in global cervical cancer elimination efforts, strengthening public understanding of HPV susceptibility and vaccine effectiveness, as well as enhancing supportive social environments within the Iranian context is essential.

BMC Public Health
Shiraz University of Medical Sciences (IR), University of Saskatchewan (CA)
Shiraz University of Medical Sciences, Vice-Chancellor for Research, Shiraz University of Medical Sciences
Good health and well-being
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon